23andMe | SPAC Presentation Deck | 47 slides

andMe · 2021-02
arc beats above · slides in the middle · loops below · scroll → 3 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON

Slide inventory

47
every slide · same image gating as the playbook
01
Slide 1
The background consists of a repeating pattern of A, C, G, T nucleotides.front_matter
Open slide detailBeat · Humble Origins
02
other
Open slide detailBeat · Humble Origins
03
The slide features headshots of four executives with their titles and associated company logos.other
Open slide detailBeat · Humble Origins
04
summarize
Open slide detailBeat · Humble Origins
05
The background contains a repeating pattern of A, C, G, T letters, referencing DNA sequencing.transition
Open slide detailBeat · Humble Origins
06
The chart highlights 23andMe's 10.7M participants compared to other well-known biobanks and research programs.show_traction
Open slide detailBeat · Early StrugglesLoop · Logic Chain
07
Uses a split-screen layout with a strong emotional quote on the left and quantitative evidence on the right.frame_problem
Open slide detailBeat · Early StrugglesLoop · Logic Chain
08
Uses a list of industry-disruptor pairs to establish a pattern of consumer-led change.argue_timing
Open slide detailBeat · Early StrugglesLoop · Logic Chain
09
The slide uses a timeline to demonstrate regulatory milestones and credibility.show_traction
Open slide detailBeat · Early StrugglesLoop · Logic Chain
10
The slide combines quantitative traction metrics with a qualitative customer story.show_traction
Open slide detailBeat · Early StrugglesLoop · Logic Chain
11
The slide highlights the cross-disciplinary background of the team (Tech, Biotech, Healthcare) and lists notable past affiliations and investors.other
Open slide detailBeat · Rising SuccessLoop · Logic Chain
12
The background features a repeating pattern of A, C, G, T letters, representing DNA nucleotides.inspire_vision
Open slide detailBeat · Rising SuccessLoop · Logic Chain
13
The background features a repeating pattern of A, C, G, T letters, referencing DNA base pairs.inspire_vision
Open slide detailBeat · Rising SuccessLoop · Logic Chain
14
The chart highlights the achievement of 10M+ genetic profiles as a critical mass point.show_traction
Open slide detailBeat · Rising SuccessLoop · Logic Chain
15
The slide uses a circular flow diagram to illustrate the network effect between consumer data and therapeutic/product output.present_framework
Open slide detailBeat · Rising SuccessLoop · Logic Chain
16
The slide highlights the user-facing product features that drive data collection for the company's database.present_solution
Open slide detailBeat · Rising SuccessLoop · Logic Chain
17
Uses a flow diagram to show the gap in the current healthcare system for BRCA testing.illustrate_case
Open slide detailBeat · Rising SuccessLoop · Logic Chain
18
Includes a footnote regarding FDA authorization for wellness reports.present_solution
Open slide detailBeat · Rising SuccessLoop · Logic Chain
19
The slide uses a grid of metrics to demonstrate the scale of the user base and their willingness to contribute data.show_traction
Open slide detailBeat · Rising SuccessLoop · Logic Chain
20
show_traction
Open slide detailBeat · Rising SuccessLoop · Logic Chain
21
The slide highlights the value proposition of the subscription service with a visual mockup of the mobile app interface.present_solution
Open slide detailBeat · The Breakthrough
22
The chart displays a combination of a bar chart for daily subscribers and a line chart for cumulative active subscribers.show_traction
Open slide detailBeat · The Breakthrough
23
Uses a visual contrast framework to illustrate the shift from one-size-fits-all to individualized care.compare_peers
Open slide detailBeat · The Breakthrough
24
The slide uses a visual flow from the product (saliva kit) to a list of integrated healthcare services.present_solution
Open slide detailBeat · The Breakthrough
25
The slide uses a DNA-themed background (A, C, G, T letters) and a numbered circle '3' to indicate a section transition.transition
Open slide detailBeat · The Breakthrough
26
The slide uses a split-screen layout with a blue background on the left for the core problem statement and a white background on the right for supporting metricframe_problem
Open slide detailBeat · The BreakthroughLoop · Cost Of Inaction
27
Uses a comparison frame to highlight competitive advantage in drug development metrics.present_solution
Open slide detailBeat · The BreakthroughLoop · Cost Of Inaction
28
The slide uses a combination of a grid of metrics for health conditions and a vertical timeline for the COVID-19 study.show_traction
Open slide detailBeat · The BreakthroughLoop · Cost Of Inaction
29
Uses a line chart for growth and Manhattan plots for qualitative improvement over time.show_traction
Open slide detailBeat · The BreakthroughLoop · Cost Of Inaction
30
Uses a funnel metaphor to represent the narrowing of research focus from broad data to specific drug targets.present_solution
Open slide detailBeat · The BreakthroughLoop · Cost Of Inaction
31
Includes a testimonial from Dr. Hal Barron of GSK.show_traction
Open slide detailBeat · Ultimate AchievementLoop · Quick Win Big Bet
32
The slide uses a horizontal bar chart format to represent drug development stages.show_traction
Open slide detailBeat · Ultimate AchievementLoop · Quick Win Big Bet
33
The slide uses a three-step process flow (Market -> Validation -> Mechanism) to justify the CD96 program.present_solution
Open slide detailBeat · Ultimate AchievementLoop · Quick Win Big Bet
34
The slide uses a three-step process flow: discovery/mechanism, validation, and development timeline.present_solution
Open slide detailBeat · Ultimate AchievementLoop · Quick Win Big Bet
35
The chart shows a clear upward trend in validated targets over time.show_traction
Open slide detailBeat · Ultimate AchievementLoop · Quick Win Big Bet
36
The background features a repeating pattern of DNA base pairs (A, C, G, T), suggesting a biotech or life sciences company.transition
Open slide detailBeat · Ultimate AchievementLoop · Quick Win Big Bet
37
The chart displays cumulative genotyped customers in millions from FY15A to FY21E.show_traction
Open slide detailBeat · Ultimate Achievement
38
The slide uses a waterfall-style progression for EBITDA and a table for key financial metrics across fiscal years 2019-2024.show_traction
Open slide detailBeat · Ultimate Achievement
39
The slide uses bar charts to project growth across two distinct business segments.show_traction
Open slide detailBeat · Ultimate Achievement
40
Includes both historical (A) and estimated (E) data points.analyze_data
Open slide detailBeat · Ultimate Achievement
41
The circular graphic serves as a visual metaphor for genetic data/genomics.size_opportunity
Open slide detailBeat · Ultimate Achievement
42
The background features a repeating pattern of DNA base pairs (A, C, G, T) on a gradient background, suggesting a biotech or life sciences context.transition
Open slide detailBeat · Ultimate Achievement
43
Slide outlines the SPAC transaction details including valuation, funding sources, and ownership retention.summarize
Open slide detailBeat · Ultimate Achievement
44
Includes disclaimer regarding warrant and equity award exclusions.analyze_data
Open slide detailBeat · Ultimate Achievement
45
The slide uses a Venn diagram to show the intersection of business units centered around the 23andMe brand.present_framework
Open slide detailBeat · Ultimate Achievement
46
The background consists of a repeating pattern of A, T, C, G letters representing DNA nucleotides.appendix
Open slide detailBeat · Ultimate Achievement
47
Includes footnote regarding restructuring costs.analyze_data
Open slide detailBeat · Ultimate Achievement